1. Home
  2. TX vs MDGL Comparison

TX vs MDGL Comparison

Compare TX & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

TX

Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

HOLD

Current Price

$37.96

Market Cap

8.5B

Sector

Industrials

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$455.14

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TX
MDGL
Founded
1961
2011
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
10.0B
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
TX
MDGL
Price
$37.96
$455.14
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$36.92
$674.45
AVG Volume (30 Days)
168.1K
317.2K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
7.13%
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$13.25
$58.28
Revenue Next Year
$6.86
$46.80
P/E Ratio
$20.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.00
$265.00
52 Week High
$45.57
$615.00

Technical Indicators

Market Signals
Indicator
TX
MDGL
Relative Strength Index (RSI) 29.78 53.04
Support Level $37.08 $416.43
Resistance Level $38.99 $463.63
Average True Range (ATR) 1.14 16.10
MACD -0.35 4.56
Stochastic Oscillator 12.44 93.17

Price Performance

Historical Comparison
TX
MDGL

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: